# Pharmaceutical Specialties, Inc., Rochester, MN – FDA Inspections

Source: https://www.keypedia.com/companies/pharmaceutical-specialties-inc/21d8b984-d2b5-4f1e-b1c4-0d27eda2ad40

> Inspection records and compliance data for Pharmaceutical Specialties, Inc. in Rochester, Minnesota. 4 FDA inspections on record, 2 Form 483s, last inspected August 15, 2025.

---

## Details

- Name: Pharmaceutical Specialties, Inc.
- FEI Number: 2150117
- Address Line 1: 1620 Industrial Dr NW
- City: Rochester
- State: Minnesota
- Zip Code: 55901
- Country Name: United States
- Address: 1620 Industrial Dr NW, Rochester, Minnesota 55901, United States
- Country: United States

## Related Documents

- [483 - Pharmaceutical Specialties, Inc. - 2025-08-15](https://www.keypedia.com/records/483/pharmaceutical-specialties-inc/9b3d4839-3ad0-494f-9de5-4f6436d35e84) — source: FDA, date: August 15, 2025
- [FDA Inspection 1274911 - Pharmaceutical Specialties, Inc. - 2025-08-15](https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/2336d78e-7de4-4d30-aba2-d308c403a491) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 15, 2025
- [483 - Pharmaceutical Specialties, Inc. - 2019-05-03](https://www.keypedia.com/records/483/pharmaceutical-specialties-inc/4eea6d7a-e4d5-4e11-845f-3031e5075c16) — source: FDA, date: May 3, 2019
- [FDA Inspection 1091169 - Pharmaceutical Specialties, Inc. - 2019-05-03](https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/480a4535-0bb5-4262-841f-4eff1aa484d6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2019
- FDA Inspection 867840 - Pharmaceutical Specialties, Inc. - 2014-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2014
- FDA Inspection 867840 - Pharmaceutical Specialties, Inc. - 2014-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2014
- [FDA Inspection 564154 - Pharmaceutical Specialties, Inc. - 2009-02-20](https://www.keypedia.com/records/fda_inspections/pharmaceutical-specialties-inc/246d65da-5eb5-47cd-ba92-c5f2e2af7768) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2009

## Related Companies

- [Whisk Products Inc](https://www.keypedia.com/companies/whisk-products-inc/42cf456d-2936-4ec5-a2dd-b2e800bf2c11)
- [Deseret Laboratories, Inc.](https://www.keypedia.com/companies/deseret-laboratories-inc/1a062a64-f1a3-4945-8952-d86c4035b3c2)
- [Topical Pharmaceuticals, Inc.](https://www.keypedia.com/companies/topical-pharmaceuticals-inc/96b397ec-23a3-4d5e-9acc-6e103fc22fd7)
- [Tower Laboratories Ltd.](https://www.keypedia.com/companies/tower-laboratories-ltd/a704e9ff-aed4-475d-b09e-67d4af62c65d)
- [Active Cosmetics Manufacturing Inc](https://www.keypedia.com/companies/active-cosmetics-manufacturing-inc/c389b0b5-171e-42bb-8b8b-82fd33d0a82d)
- [The Tender Corporation](https://www.keypedia.com/companies/the-tender-corporation/86a7c0de-a5cf-4f80-96fe-eceed91a4c5e)
- [Intercos America Inc.](https://www.keypedia.com/companies/intercos-america-inc/cec0bbc0-f619-4121-ab40-2d9a8b04db97)
- [Premier Brands Of America Inc.](https://www.keypedia.com/companies/premier-brands-of-america-inc/edc16d09-7daf-4279-a2d0-99df17ac18b8)
- [SHL Pharma LLC](https://www.keypedia.com/companies/shl-pharma-llc/bf3ea56c-78f5-4e22-9b0f-ffe5ee693aa3)
- [Perrigo New York, Inc.](https://www.keypedia.com/companies/perrigo-new-york-inc/e460cce5-5bfc-4b87-b419-819e0fc7a250)

## Related Officers

- [Scott A. Golladay](https://www.keypedia.com/people/scott-a-golladay/78c90066-7212-4442-900c-5cdcb677aeec)
- [Beatrix D. Hippe](https://www.keypedia.com/people/beatrix-d-hippe/4a5a5258-3099-46cd-9e56-2dce60668ac5)
- [Travis V. Hull](https://www.keypedia.com/people/travis-v-hull/1f3b5843-29ed-4291-8a8a-a2bf3ac36988)
